NICE Ltd. Sponsored ADR is an American depositary share representing one ordinary share of NICE Ltd., a global enterprise software company. NICE provides cloud-based and on-premises solutions for customer engagement, workforce optimization, and operational efficiency, along with financial crime and compliance tools that help organizations detect risk, prevent fraud, and support regulatory requirements. The company serves businesses across industries such as financial services, government, telecommunications, retail, and public safety. Its software portfolio is built around AI-driven analytics and automation, enabling organizations to manage customer interactions, improve internal operations, and strengthen compliance workflows. NICE Ltd. Sponsored ADR gives U.S. investors access to a diversified software business focused on mission-critical enterprise applications used in large, data-intensive environments.
WebsiteNICE 1, 2, 3
Ra'anana, 4310602
Israel
Detailed price information for Nice Ltd ADR (NICE-Q) from The Globe and Mail including charting and trades.
NICE stock has retreated sharply over the past few years, yet current market multiples flag it as potentially undervalued while the broader value checks only give a mixed verdict. After a long drawdown, the question for investors is whether the recent share price level around US$310.50 properly reflects that split view. Over the past 5 years, NICE has delivered a decline of about 66.9%, which leaves long term holders with heavy losses and frames any valuation case against a weak return...
NICE (TASE:NICE) reported that Bluecrest Health Intelligence has adopted its CXone platform to overhaul contact center operations using AI. The healthcare provider is using CXone to support a broad shift toward AI driven customer interactions and contact center processes. NICE highlighted operational efficiency, customer access, analytical insight, and resilience as key outcomes from the Bluecrest deployment. The case adds a high profile healthcare reference client for NICE at a time of...
NICE Ltd. (NASDAQ:NICE) has continued to expand its enterprise footprint throughout August 2026, securing back-to-back major client wins for its cloud-native CXone platform. On August 12, European tech retailer Currys selected NICE CXone to unify customer interactions across every stage of the journey, from purchase to ownership and support. Management noted that the platform supported […]
Detailed price information for Nice Ltd ADR (NICE-Q) from The Globe and Mail including charting and trades.
Investors talking about NICE also mention
| # | Name | Attention |
|---|---|---|
| 1 | Five9 Inc.FIVN | 0%0 |
| 2 | VRNT - Verint Systems Inc. | —— |
| 3 | Elbit Systems Ltd.ESLT | 0%+0 |
| 4 | Surgery Partners Inc.SGRY | 0%0 |
| 5 | Lyell Immunopharma, Inc.LYEL | 0.01%new |
| 6 | SPNS - Sapiens International Corporation N.V. | —— |
| 7 | Qualys, Inc.QLYS | 0%-0.01 |
| 8 | SkyWest Inc.SKYW | 0%new |
| 9 | monday.com Ltd.MNDY | 0%+0 |
| 10 | CIVI - Civitas Resources, Inc. | —— |
What share of all stock conversation is about NICE?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% +0 | 0% 0 | 0% 0 |
Of the messages about NICE that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 100% | 100% 0 | 67.88% -15.35 | ||
| Bearish | — | 0% | 0% 0 | 32.12% +15.35 |
Of the messages about NICE that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | — | 14.26% | ||
| Analysts | — | — | — | 11.17% | ||
| Controversies | — | — | — | 0.03% | ||
| Earnings | — | — | — | 16.63% | ||
| Macro | — | — | — | 9.95% | ||
| Technical Analysis | — | — | — | 47.96% |
Of the messages about NICE, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 33.33% | 16.67% | 22.12% | ||
| Newcomers | — | 66.67% | 83.33% | 77.88% |